Special report highlights potential therapeutic agents, vaccines for COVID-19
- Details
- Category: Research
Since the first reports of a new coronavirus disease in Wuhan, China, in December 2019, COVID-19 has spread rapidly across the globe, threatening a pandemic. Now, researchers from CAS, a division of the American Chemical Society specializing in scientific information solutions, have issued a special report in ACS Central Science.
Low-dose aspirin linked to reduced liver cancer risk
- Details
- Category: Research
Among adults at high risk of liver cancer, those who took low-dose aspirin were less likely to develop the disease or to die from liver-related causes. The findings come from an analysis published in the New England Journal of Medicine and conducted by a team led by investigators at the Karolinska Institutet, in Sweden, and Massachusetts General Hospital (MGH).
Immune cells against Alzheimer's?
- Details
- Category: Research
Scientists at the German Center for Neurodegenerative Diseases (DZNE), the Ludwig-Maximilians-Universitaet (LMU) Munich and Denali Therapeutics (South San Francisco, CA, USA) have developed an approach to stimulate immune cells of the brain in such a way that they might possibly provide better protection against Alzheimer's disease. Their report has been published in the journal EMBO Molecular Medicine.
Gut bacteria can penetrate tumors and aid cancer therapy
- Details
- Category: Research
Researchers at the University of Texas Southwestern Medical Center and University of Chicago have discovered that bacteria that usually live in the gut can accumulate in tumors and improve the effectiveness of immunotherapy in mice. The study, which will be published March 6 in the Journal of Experimental Medicine (JEM), suggests that
Individual response to COVID-19 'as important' as government action
- Details
- Category: Research
How individuals respond to government advice on preventing the spread of COVID-19 will be at least as important, if not more important, than government action, according to a new commentary from researchers at the University of Oxford and Imperial College London in the UK, and Utrecht University and the National Institute for Public Health and the Environment in the Netherlands.
Preventing spread of SARS coronavirus-2 in humans
- Details
- Category: Research
Several coronaviruses circulate worldwide and constantly infect humans, which normally caused only mild respiratory disease. Currently, however, we are witnessing a worldwide spread of a new coronavirus with more than 90,000 confirmed cases and over 3,000 deaths. The new virus has been named SARS coronavirus-2 and has been transmitted from animals to humans. It causes a respiratory disease called COVID-19 that may take a severe course.
Newly discovered brain response to obesity drug may inform future treatments
- Details
- Category: Research
The U.S. Food and Drug Administration-approved drug liraglutide has been shown to help obese patients lose weight by suppressing their appetite. However, where and how the drug acts in the brain was not fully understood, until now. A new preclinical study from the Perelman School of Medicine at the University of Pennsylvania, published in Science Translational Medicine today, shows how
More Pharma News ...
- COVID-19 a reminder of the challenge of emerging infectious diseases
- Study reveals how drug meant for Ebola may also work against coronaviruses
- Study sheds light on how a drug being tested in COVID-19 patients works
- HKUST scientists shed light on COVID-19 vaccine development
- Regular walnut consumption linked to health and longevity in women
- Cross-talk between enzymes that read and correct recipes in the cookbook of life
- Research shows new drug helps to preserve brain cells for a time after stroke